malignant lymphomas

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:unicentric_Castleman_disease
gptkbp:affects lymphatic system
gptkbp:associated_with gptkb:Epstein-Barr_virus
gptkb:HIV/_AIDS
autoimmune diseases
gptkbp:can_lead_to organ damage
secondary cancers
infection complications
gptkbp:end_of_life varies by type
higher for Hodgkin lymphoma
lower for aggressive Non-Hodgkin lymphoma
gptkbp:has_style gptkb:healthcare_organization
gptkb:Non-Hodgkin_lymphoma
https://www.w3.org/2000/01/rdf-schema#label malignant lymphomas
gptkbp:is_characterized_by abnormal lymphocyte proliferation
lymph node enlargement
systemic symptoms
extramedullary involvement
gptkbp:is_linked_to environmental factors
radiation exposure
genetic mutations
chemical exposures
gptkbp:is_often_used_in gptkb:Africa
gptkb:Europe
gptkb:Asia
gptkb:Australia
gptkb:North_America
gptkbp:is_popular_in common in adults
rare in children
gptkbp:is_protected_by healthy lifestyle
early detection
vaccination against viruses
gptkbp:is_studied_in research studies
clinical trials
epidemiological studies
gptkbp:managed_by multidisciplinary teams
palliative care teams
supportive care teams
gptkbp:number_of_stages Stage I
Stage II
Stage III
Stage IV
gptkbp:risk_factor age
family history
weakened immune system
gptkbp:social_responsibility biopsy
imaging tests
gptkbp:symptoms weight loss
fever
night sweats
swollen lymph nodes
gptkbp:treatment radiation therapy
chemotherapy
oncologists
hematologists
stem cell transplant